Related Experiment Video
Updated: Jun 9, 2025

Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
Prior Authorization Requirements and Medicaid Enrollees' Use of Tobacco Cessation Medications, Colorado, 2023
Marcus Dillender1, Robin Mermelstein1
1Marcus Dillender is with the Department of Economics, Vanderbilt University, Nashville, TN. Robin Mermelstein is with the Department of Psychology and the Institute for Health Research and Policy, University of Illinois at Chicago.
Abstract:
Despite tobacco cessation medications being a first-line treatment for quitting smoking, a majority of Medicaid programs require health care providers to obtain prior authorization before prescribing them. We examined the impact of Colorado's Medicaid program removing its prior authorization requirement for these drugs on their use and estimated the additional number of Coloradoans who used these therapies in 2023 because of the policy change. The findings indicate that these requirements decrease low-income people's use of these medications. (Am J Public Health. 2025;115(1):42-46. https://doi.org/10.2105/AJPH.2024.307868).
Related Concept Videos
Inhaled Medications
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
COPD: Management Using Bronchodilators and Corticosteroids
Preventive Healthcare Services
Chronic Obstructive Pulmonary Disease-I: Introduction

